SA’s BCG booster trials seek low-cost weapon against virus
Researchers expect preliminary results within six months in the year-long trial.
Wendell Roelf - The idea of testing the BCG vaccine in Africa against Covid-19 was bound to cause controversy, yet officials say efforts underway could, if successful, give the con
...
If you are an active subscriber and the article is not showing, please log out and back in. Free access to articles from 12:00.
Comments
Namibian Sun
No comments have been left on this article